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Abstract 
 
Human Papillomavirus (HPV) is a group of more than 150 virus that can cause genital 
warts and cancers of the oropharynx, cervix, vagina, vulva, penis, and anus. A preventive 
vaccine currently exists that protects against seven oncogenic HPV strands and two strands that 
cause genital warts. Current guidelines for HPV9 vaccination consist of a 2-dose series delivered 
at 0 and 6 months for males and females ages 9-14, and a 3-dose series delivered at 0, 2, and 6 
months for those ages 15-26.   
While up-to-date (UTD) vaccination rates have increased across the Unites States, in 
2017, only about 52.4% of adolescents in central city areas were vaccinated and those outside of 
a metropolitan area lagged behind at 42.4%. In Kentucky specifically, the Cumberland Valley 
Area Development Distract (CVADD) has among the highest incidence rates of both cervical 
and head and neck cancers compared to the other area development districts in the state. As a 
result, the Cumberland Valley District Health Department has decided to utilize their existing 
relationships within Clay, Jackson, and Rockcastle County to implement a School-Based HPV9 
Vaccination Clinic in the middle schools in the aforementioned counties. 
The school-based clinic will begin with recruitment efforts at back-to-school events 
within the counties involved. The clinics will be deployed in the schools with the first dose of the 
series offered in August and September for five days each month, and the second dose will be 
available in March and April. Retention efforts will include paper and text message reminders as 
well as incentives for initiating and completing the 2-dose series. 
Performance evaluation measures will be collected throughout the project; consent forms 
will be completed by parents or guardians. A process evaluation will consist of clinic logs and 
parent and guardian surveys to assess barriers to vaccination and their satisfaction with the 
vaccine clinics. Primary outcome measures will be vaccination initiation and completion rates. 
Secondary outcomes will focus on existing knowledge of HPV vaccination and biases associated 
with the HPV vaccine and other immunizations; these will be assessed through the University of 
North Carolina National Parent Survey. We hope that a School-Based HPV9 Vaccination Clinic 
will increase UTD vaccination rates among youth in the CVADD, foster a passion that allows us 
to expand this program to the remaining counties in the CVADD, and decrease HPV-associated 
cancer rates in this region of Kentucky. 
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Target Population and Need 
 
Public Health Need 
Human Papillomavirus (HPV) is a group of more than 150 related viruses. HPV can be 
transmitted through skin-to-skin intimate contact. It is most commonly spread through 
participating in oral, vaginal, or anal sex with someone who carries the virus. The transmission 
of the virus is common partly because most infected individuals are asymptomatic. Some people 
will develop symptoms years after being initially infected (i.e., persistent infection), while in 
others, the virus clears on its own. Nearly all men and women become infected with HPV at 
some point in their lives1. 
 When HPV does not clear on its own, it can cause detrimental health effects such as 
genital warts and cancer. The types of cancers that HPV can cause include cancers of the 
oropharynx, cervix, vulva, vagina, penis, and anus1. Each year, about 39,800 new cancer cases 
are diagnosed in parts of the body where HPV can be found. Of those cases, HPV is the cause of 
about 31,500 of the cancers, which equates to nearly 80% of cases. These cancers often have 
relatively benign symptoms until they are advanced and hard to treat. Cervical cancer is the most 
common HPV-associated cancer among women, and head and neck cancer is the most common 
HPV-associated malignancy among men2. 
 The current Advisory Committee on Immunization Practices (ACIP)-recommended HPV 
vaccine protects against infection from nine different HPV strands, seven of which cause 
cervical, head and neck, vaginal, vulvar, or anal cancers and two of which cause genital warts. 
HPV vaccination is indicated for both males and females who are 9-26 years old. For those aged 
9-14, the vaccination is given in a 2-dose schedule wherein the second vaccine is given 6-12 
months after the first dose3. For adolescents and young adults aged 15-26, 3-doses of the HPV 
Wiethorn 5 
vaccine is recommended; the second immunization is administered 2 months after the first, and 
the third is given 6 months after the first shot4. In addition, the Food and Drug Administration 
approved the use of the HPV9 vaccine for men and women aged 27-45 in October 2018; 
vaccination guidelines for the older catch-up pool of adults are forthcoming from the ACIP5. The 
HPV vaccine is up to 98% efficacious in preventing cervical cancer when the complete 
vaccination series is administered at the appropriate age. However, barriers exist to receiving the 
initial HPV vaccine as well as subsequent doses6. These barriers include, but are not limited to, 
geographical and socioeconomic barriers to receiving preventive healthcare, absence of a strong 
and consistent provider recommendation, and limited awareness of the existence of the vaccine 
and HPV’s link to cancer. Additionally, the vaccine has been encountered with controversy due 
to moral, religious, political, medical, gendered, and sociocultural beliefs7. 
Target Population 
Since the introduction of the HPV vaccine in 2006, vaccination rates have increased 
across the United States (U.S.) over the last 13 years, although they are still suboptimal 
compared to other adolescent vaccine rates such as Tetanus-Diphtheria-Pertussis (Tdap) and 
meningococcal conjugate8. About half of adolescents across the country were up-to-date (UTD) 
on the HPV vaccine series in 2017 and about two-thirds had received at least the first dose of the 
vaccine series. This is an increase of about 5 percentage points over the past 5 years9. However, 
Kentucky adolescent male and females continue to lag behind the rest of the country when it 
comes to UTD HPV vaccination rates (Figure 1).  
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 Lower rates of HPV vaccination in Kentucky could be due in part to the rural geography 
of the state. In the U.S., those that live in a metropolitan statistical area have UTD HPV 
vaccination rates as high as 52.4% when living in a central city. Those that live outside of a 
metropolitan statistical area have vaccination rates of 42.4%. Due to this data, the Centers for 
Disease Control and Prevention (CDC) has prioritized increasing HPV vaccination coverage 
rates in rural communities9. The Appalachia region of the U.S., comprising 420 counties in 13 
states, has higher incidence of all cancer types, including head and neck cancers and cervical 
cancers, and lower HPV vaccination rates than its non-Appalachian counterparts10,11. As such, 
we identified the Cumberland Valley Area Development District (CVADD) in Appalachian 
Kentucky as a rural region in which there was a particular need for a School-Based HPV9 
Vaccination Clinic. As mentioned previously, cervical and head and neck cancers are two of the 
most common complications of HPV, and this district is amongst the highest in the state in both 
cervical cancer incidence and mortality, as shown in Figure 2 and 3 respectively. The CVADD is 
also amongst the highest ADD for oropharyngeal cancer rates, as shown in Figure 412. 
Figure 1: HPV Vaccination Rates in Kentucky versus the U.S., 2017 
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A high rate of cervical cancer is a sentinel marker for many larger health care issues 
indicating that there may be broader problems to access to care in these regions13. In addition, 
CVADD scores lower on many social determinants of health compared to the entire state of 
Kentucky. For example, from 2012-2016 about 85% of adults aged 25 or older have graduated 
high school in Kentucky, while only about 73% of adults graduated high school within the 
targeted district. The median household income within the state is $44,811; the median 
household income within CVADD is more than $14,000 lower at $29,584. There was a higher 
teen-birth rate in the CVADD than within the state of Kentucky from 2011-2015; 58 per 1,000 
women aged 15-19 compared to 37, respectively14. Unfortunately, HPV vaccination data at the 
county or ADD level is unavailable for Kentucky.  
 Although we hope to eventually implement our program throughout the entire CVADD, 
we want to first pilot our program in three counties in the region in order to ensure program 
Figure 2: Cervical Cancer 
Incidence Rates by KY County 
Figure 3: Cervical Cancer 
Mortality Rates by KY 
County 
Figure 4: Oropharyngeal Cancer Incidence Rates by KY County 
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success and establish best practices. We have decided to utilize the existing relationship between 
the Cumberland Valley District Health Department (CVDHD) and the counties in which it 
represents – Jackson, Rockcastle, and Clay – in order to complete this pilot. Specifically, our 
program will target the parents and guardians of middle-school aged children that attend public 
middle schools within these three counties. Jackson County is home to Jackson County Middle 
School (JCMS), Rockcastle County contains Rockcastle County Middle School (RCMS), and 
Clay County has Clay County Middle School (CCMS). CCMS currently has 488 students 
enrolled within their middle school that is comprised of two grades. We estimate that 
approximately 250 students will be in the 7th grade each of the three years our program is 
ongoing. JCMS currently has 448 students and RCMS has 664 students. We estimate that there 
will be approximately 150 6th graders and 220 6th graders in the respective schools during the 
length of our program. CCMS will participate in the program for three years, RCMS will 
participate for 2 years, and JCMS for one. This would equate to 1,340 students with potential 
participation in our School-Based HPV9 Vaccination Clinic over the three years. Recruitment 
initiatives will begin at community Back-to-School events in which information will be provided 
to parents and students regarding the HPV vaccine series. For more details, see the 
“Recruitment” section on page 13 of this application. Recruitment and retention efforts will be 
maintained through regular contact with students while at school. 
Community Resources 
The three counties in which our program will be implemented are served by the 
Cumberland Valley District Health Department (CVDHD). Based on the success of our pilot 
project, we hope to foster a relationship between the district health department and the other 
independent county health departments in the CVADD in order to disseminate our project to 
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other school settings. The CVDHD clinics offer Tdap, influenza, and Measles-Mumps-Rubella 
(MMR) immunizations15. While they will need to be trained on HPV vaccination, specifically, 
there are already staff that are trained to administer routine immunizations. The three counties 
represented by the CVDHD also have their own local health departments in their respective 
counties. These local health departments will provide resources, ideas, partners, and personnel to 
help facilitate our program. Specifically, Healthy Clay, a coalition of organizations and 
individuals working together to promote policy and community change for Clay County, has a 
goal to increase school initiatives within their county. The Cumberland Valley District Cancer 
Council (CVDCC) partners with the Kentucky Cancer Program and the Kentucky Cancer 
Consortium, managed by the University of Kentucky (UK) Markey Cancer Center (MCC), to 
discuss strategic planning to address local cancer problems and implement initiatives. The 
CVDCC meets quarterly and consists of representatives from the county and district health 
departments, hospitals, government agencies, healthcare providers, universities, businesses, labor 
unions, schools, tobacco coalitions, and cancer survivors16. Additionally, Clay County 
Community Hospital and Rockcastle Regional Hospital and Respiratory Care Center exist within 
Clay and Rockcastle counties respectively14. Somerset Community College is located within this 
ADD and offers an accelerated Licensed Practical Nurse (LPN) degree. Nurses from these 
surrounding hospitals and new graduates from the community college can be hired or volunteer 
to administer vaccinations to adolescents as part of our program. 
 Our School-Based HPV9 Vaccination Clinic will strengthen current relationships among 
the health departments and the public middle schools within the counties. The proposed program 
will enhance the number of adolescents that are reached by making it more convenient and 
accessible for them to receive the complete vaccine series, and therefore prevent the spread of 
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HPV and future development of HPV-associated cancers caused by the virus. We will work with 
the aforementioned parties to assess changing community needs in order to adapt the program as 
needed throughout the longevity of the grant to provide as many adolescents as possible the HPV 
vaccine series. 
Program Approach 
 
School-Based HPV9 Vaccination Clinic 
 This program physically takes place within the school system and consists of 
collaborations between the school and local health departments, private healthcare providers, and 
community healthcare services. School-based vaccination programs include a variety of 
activities, including at least two of the following components: (1) immunization education and 
promotion, (2) assessment and tracking of vaccination status, (3) referral of under-immunized 
school or childcare center attendees to vaccination providers, or (4) provision of vaccines17. 
Other activities that have been implemented within these school-based programs are telephone 
reminder systems, incentives to increase participation, and community advocacy18. 
 The timeline for school-based vaccination interventions vary based on the delivery 
schedule of the immunizations given and the flexibility of the staff involved. When implemented 
based on the HPV9 vaccine, those implementing the program would need to follow the standard 
vaccination series based on the age of the youth (i.e., 2 doses for ages 9-14). Ideally, both doses 
of the vaccine should be given during the school year in order to avoid a delay in vaccination 
administration during the summer months. Our program will be based on iterations of school-
based HPV vaccination conducted in Guilford, North Carolina and eastern Kentucky. In previous 
iterations of school-based HPV vaccination programs such as in North Carolina, plans have been 
implemented in a very fixed timeline, in which the first vaccine of the series would only be 
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offered to students for one day. Then, the administrators, usually nurses, would come back two 
and six months later to administer the subsequent doses19. The program has also been previously 
implemented in a way in which students have the opportunity to receive their first dose over a 
longer period. For example, as previously implemented in the Lake Cumberland region of 
eastern Kentucky, the first dose of the vaccine series was offered from August through 
November18. The second dose of the vaccine would, therefore, be available from March through 
June.  
Evidence-Base 
 Since 2009, vaccination programs in schools and organized childcare centers have been 
recommended as evidence-based interventions on The Community Guide according to two 
systematic analyses conducted by the Community Preventive Services Task Force17. Twenty-
seven studies were included in these analyses. Based on these analyses, vaccination rates 
increased by a median of 47 percentage points whenever a school-based program was 
implemented. The task force considered this to be strong evidence of effectiveness. In 23 of 
these 27 programs, immunizations were provided on-site and included educational materials, 
parental notification and consent forms, and additional opportunities to obtain the offered 
vaccinations (e.g., a “make-up” schedule). Multi-component interventions could potentially 
show increased effectiveness17.  
Positive outcomes have also been discovered when specifically concentrating on the HPV 
vaccine. The American Academy of Pediatrics conducted a review of 51 studies that shared a 
focus of increasing HPV vaccination rates. Researchers found environmental interventions, 
particularly school-based programs, to be the most successful. They stated that school-based 
vaccination programs had two major advantages that contributed to their success when compared 
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to other interventions: (1) increased access to the HPV vaccine and (2) that these interventions 
were able to reach a large, diverse population without regards to individual access to 
healthcare20. In addition, a study in North Carolina was conducted in which six middle schools 
offered the 3-dose HPV vaccine series to their female students. Of the 181 girls who initiated the 
vaccine series in the school-based clinics, 80% received all three doses of the vaccine19. A 
similar school-based intervention completed in two high schools in eastern Kentucky, offered the 
3-dose vaccine series to both female and male students. The vaccine series was initiated in these 
school-based clinics by 70% of vaccine-naïve students. Of the 315 students that initiated the 
vaccine series as part of the clinics, 88% completed all three doses of the vaccine18. 
Setting 
 When completing our community needs and resource assessment, we identified three 
counties within the CVADD with elevated HPV-associated cancer rates and a stable public 
health infrastructure coordinated by the CVDHD. These three counties were Clay County, 
Jackson County, and Rockcastle County. Each of these counties possess their own public health 
department that works closely with the CVDHD. In addition, Clay and Rockcastle counties each 
have a hospital, leading to additional healthcare resources as needed. Therefore, we decided to 
implement our program within the public middle schools within these three counties: Clay 
County Middle School (CCMS), Jackson County Middle School (JCMS), and Rockcastle 
County Middle School (RCMS). Implementation in the middle schools allows us to access the 
majority of 11-12 year-olds, all of whom are indicated to receive the HPV vaccination series 
based on age. 
Community Advisory Group 
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 Assembling an effective Community Advisory Group (CAG) is an essential part to 
ensuring the success of this intervention. A School-Based HPV9 Vaccination Clinic will be 
dependent on the school systems in the area as well as local agencies. In order to form this CAG, 
we have identified key community members who are known in the area and are familiar with the 
resources within the community. Inviting staff from the CVDHD will be essential in order to 
expand upon vaccination programs already implemented in the region. Members of the school 
boards and principals of the middle schools in which the program will be implemented are also 
integral as these are the locations in which the intervention will take place. Parents will also be 
invited in order to gauge their perspective on how to best reach most parents with regards to 
giving consent for the vaccination series. A pediatrician, dentist, and pharmacist will be asked to 
join the group to give their expertise on the safety, efficacy, and need for vaccines. A nurse will 
also be in the group as nurses will be the primary staff administering the HPV vaccine. As one of 
the largest expected barriers to this program is the negative connotation that administering the 
vaccine will encourage teenagers to engage in risky sexual behavior, a prominent church leader 
from the area will be recruited for the CAG; he will be beneficial to overcoming negative beliefs 
about the cancer-preventing vaccine. Additionally, we will recruit two middle school 
representatives to be a part of the CAG as the students will be the ones participating in the 
intervention and their opinions and influence are essential to successful program implementation. 
We will gather interest from the Student Government, Future Farmers of America, and 
Fellowship of Christian Athletes presidents, captains of various sports teams, and leaders of the 
drama club and band in order to spread awareness of the program.  
The CAG will meet before the Back-to-School event each year and at the beginning of 
each quarter in order to maintain relationships, provide updates, gain feedback, and assure that 
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high quality healthcare is provided to both the participants and the community. By meeting this 
frequently, we also hope to remain up-to-date in information regarding HPV, HPV-associated 
cancers, and the HPV vaccine. The table below provides a list of the CAG members. 
Table 1: Community Advisory Group Members 
Lainey Greene, MPH 
PD, Cumberland Valley Health Department 
Margaret Robertson, MD 
Pediatrician 
Megan Wiggins 
Member, Clay County School Board 
Paul Chang, PharmD 
Pharmacist 
Michael Robin 
Principal, RCMS 
Michaela Sherman, RN, BSN 
Nurse 
To Be Named 
Parent, Jackson County Middle School 
Anastasia Kennedy, DMD 
Dentist 
Scott Wees 
Pastor 
Eryne Wiethorn 
Program Coordinator 
Gabriella Hamilton 
SGA President, JCMS 
To Be Named 
Student Representative #2 
 
Recruitment 
 Before we begin recruiting students to participate in the School-Based HPV9 Vaccination 
Clinic, it is crucial that we address potential barriers to program implementation. One of the 
barriers that we will likely face as we begin to recruit individuals is pushback from 
parents/guardians who do not want their children to receive the vaccination due to negative 
biases associated with it. This is why we plan to hold an educational event at the schools before 
the recruitment process begins. This event will take place at community Back-to-School events 
and be intended for students who are eligible to receive the vaccine series, their 
parents/guardians, teachers and school administrators, and any other community member that is 
interested in the information. These events are typically held after school and regular business 
hours in order to encourage attendance. All of our community stakeholders will be present at the 
event and are encouraged to invite guests who they know will benefit from HPV-related 
education. At the event, local healthcare providers will lead a discussion about the safety and 
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efficacy of the HPV vaccine. This will be followed by an update about the epidemiology of 
HPV-associated health problems in the region from the director of the CVDHD. Next, a member 
of the community living with cervical cancer will give her story to the audience. Our portion of 
the event will end with an open forum in which parents/guardians, in particular, are encouraged 
to ask any questions they feel need to be answered before giving their consent to HPV vaccine 
administration in the school. We will also have representatives present at a booth throughout the 
entirety of the Back-to-School event in order to answer these questions and give parents and 
guardians the opportunity to fill out consent forms for their children and the pre-vaccination 
parent survey. 
 The official recruitment process will begin with consent forms that will be distributed to 
parents. The forms will be available at the Back- to-School Events and taken home with the 
students in the 6th grade at RCMS and JCMS and the students in the 7th grade at CCMS on their 
first day of class. The parents of 6th and 7th graders at the respective schools will also be sent a 
link via email to complete the consent form online for convenience and to decrease the chance of 
students losing consent forms either before or after giving them to their parents. Each consent 
form will gather information on the student’s demographics, past HPV vaccination history, and 
the form will ask for documentation of vaccine administration, if possible. The form will also ask 
for both the consent of the parents to administer all doses of the HPV immunization that have not 
yet been given to the students as well as consent to collect data from parents and guardians in the 
form of pre- and post-vaccination surveys. If the student is given consent to receive the vaccine 
series, the parent will be asked to provide the student’s insurance information, if applicable, in 
order to bill for the vaccine doses. The consent forms will ask information that will assist the 
nurses in filling out the vaccine administration questionnaire. The HPV9 Vaccine Parent Consent 
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Form is available as Appendix A. All students who have returned parental consent forms, either 
over the internet or in-person, will be asked for their assent before participating in our 
intervention. The parent/guardian and/or student will have the option to discontinue participating 
in the intervention at any time. 
Implementation of Program 
 Our School-Based Clinic will operate with two different cycles available each year. In the 
first cycle the 2-shot series will be available in August and March; the second cycle will be 
available in September and April. The first immunization in the HPV vaccine series will be 
available to the 6th or 7th graders who returned parental consent forms among the three selected 
middle schools in August. Three nurses, the Program Coordinator (PC), and graduate-level 
student research assistants will visit each school for a total of 5 days. During those days, students 
will be able to visit the nurse’s office in order to receive their vaccination. They will be 
encouraged to do this during either a lunch period, study hall, or any other free periods the 
student may have so as not to interfere with their academic curriculum. Once they arrive, the 
nurses will identify the student’s pre-filled vaccine administration questionnaire and be asked if 
they feel sick that day in order to complete the form. Female students will also be asked if there 
is any chance they are pregnant. Next, they will be sent to the nurses who will review the 
questionnaire and administer the vaccination if deemed appropriate. The research assistants will 
provide them with the current HPV Vaccine Information Statement (VIS), a raffle ticket to be 
entered into a prize drawing, and a reminder slip for their next vaccination. They will also 
document the date of the administration or any reasons the vaccine could not be administered. 
The students will be asked to wait at least 15 minutes before leaving the nurse’s office in order to 
be observed for syncope or other adverse reactions. If any adverse events do occur, these will be 
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documented for program research purposes as well as documented officially through the FDA 
Adverse Event Reporting System (FAERS). The PC will assist with observing the students and 
overseeing the tasks of the graduate research assistants (GRA) in order to monitor for fidelity 
and intervene in which the outlined processes are not followed. 
 All data collected as part of the School-Based Vaccination Clinic will be incorporated 
into a holistic medical record for each adolescent who participates. This medical record will 
contain their demographic information, primary care provider or pediatrician, vaccine 
administration data, allergies, any adverse events that occur due to the HPV9 vaccine, and 
insurance information. This will allow the implementation team to take a more comprehensive 
approach to healthcare for the children involved and maintain better tracking records so fewer 
students are lost to follow-up. Each record will be kept with the intent to share with the 
pediatrician or healthcare provider who primarily cares for the child. 
 A similar process will take place six months later during March in order for students to 
receive the second vaccine in the 2-dose series. Before the second dose is administered, the 
parents/guardians and students will receive reminders of the upcoming vaccine administration. 
These reminders are described in more detail under the “Retention” section on page 18. We will 
repeat the process again with the first vaccination administered in September and the second in 
April. The first year of the program will be a pilot period in which CCMS will receive the 
intervention. During this period, the Program Director (PD) and PC will monitor closely for 
program fidelity, assess areas in which quality improvement measures can be implemented, and 
determine and mitigate barriers to program implementation. We will also make efforts to assess 
that all program materials are medically accurate and age, culturally, and linguistically 
appropriate for our adolescent and parent/guardian populations. In the second year of the grant, 
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both CCMS and RCMS will have the School-Based HPV9 Vaccination Clinic intervention while 
JCMS serves as the control. In the final year of program implementation, all three middle 
schools will receive the intervention in following with the wait-list control method. Appendix B 
contains calendars depicting when the immunizations will be available at each school. 
 Training of all members participating in program implementation will be conducted at the 
beginning of each school year. These trainings will consist of topics such as appropriate ways to 
interact with adolescents and parents/guardians, sensitivity and inclusivity training, HPV and its 
associated vaccine education, and program implementation training. A shortened version of these 
sessions will be conducted before the second semester of each school year for any new members 
to the implementation team and as a refresher for existing members. Additionally, the nurses 
administering the vaccine will have a more in-depth training concerning vaccine administration. 
Impact 
 While it is difficult to determine the broader impact of the school-based vaccination 
intervention for the HPV immunization within Kentucky and the U.S., there have been positive 
data related to this type of public health intervention in both Canada and Australia. Women who 
received the HPV vaccine as part of a school-based program in Alberta, Canada had fewer high-
grade cervical abnormalities; these cervical abnormalities can often be the first step in 
identifying a cervical cancer diagnosis. These women also had higher rates of cervical screening, 
which may indicate that they exhibit a greater overall knowledge about their reproductive health. 
However, these results only held their significance when all three doses of the vaccination were 
administered21. In April of 2007, Australia commenced a nationwide vaccination program that 
targeted 12- and 13-year old girls in schools, a “catch-up program” in schools for girls aged 14-
17, and a community-based program for women aged 18-26. A study in Victoria, Australia, in 
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which they compared cervical abnormalities amongst girls who were eligible for vaccination in 
the school-based program, found that a lower risk of any histologically confirmed high-grade 
cervical abnormality was found for women who had received any HPV vaccination compared 
with unvaccinated women. This effect was observed to be strongest in those that had received the 
complete vaccination series22. Reduced incidence of cervical abnormalities will, hopefully, lead 
to lower rates of cervical cancer within Australia and Canada. By building upon previous school-
based vaccination interventions and adapting for local context, we hope to reproduce this impact 
in the CVADD in Kentucky. 
Retention 
 Retention is crucial for the success of a School-Based Vaccination Clinic for the HPV 
Vaccine, as to receive maximum effectiveness of the vaccine, both doses have to be given at the 
indicated interval. Most students participating in the intervention should already be attending 
school almost every day, so the potential barrier to retention lies outside of not being able to 
make it to the site of the intervention. However, the students must be reminded to report to the 
vaccination clinic within the school on the appropriate days 6 months after their first vaccination. 
One approach in which this will be addressed throughout the program is by sending reminders to 
the student’s home highlighting the child’s next immunization due date. A paper reminder will 
be sent home with each student approximately one week before their next vaccine in the series is 
due. Additionally, parents will receive a text message approximately one day before their child is 
due to receive their next vaccination. The idea behind both the text message and letter is that the 
student and parent will each be notified by both reading the letter and receiving the text message 
or having the messaged relayed to them. However, if the student never gives their 
parent/guardian the letter or the parent/guardian forgets to tell their child about their scheduled 
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vaccination, they each will each be reminded at least once. Although the students will be 
encouraged to receive their vaccination in the School-Based Clinic, these reminders will also 
provide information on how to end program participation if they wish to do so. 
 There will also be incentives in order to increase both participation and completion of the 
program. If a student completes the entire vaccination series, they will be invited to participate in 
a pizza party. This will be offered to all students whether they completed the entire series at the 
School-Based Clinic or finished the series that was already started at a pediatrician’s office or 
other health center. This is designed so that more students will want to participate in the program 
through its entirety, rather than just receive one dose in the series. Additionally, students will 
receive a raffle ticket for every HPV vaccination they receive at school. They will have the 
opportunity to enter these raffle tickets to receive a basket in a prize drawing held on the day of 
the pizza party. Some examples of baskets will include a movie basket, a Kentucky sports basket, 
and a lotion/skin care basket. Our hope is that if peer leaders within the middle schools 
participate in our program, they will allow other students to be exposed to our intervention 
through observational modeling. Eventually, we believe that participating in the School-Based 
HPV9 Vaccination Clinic can become the social norm, and those that did not participate in the 
clinic initially will be motivated due to fear of missing out on the pizza party and chance to win 
prize baskets. 
 While there will be many measures taken, such as text messages and paper reminders and 
posters created and hung in school, in order to assure that students are reminded to participate 
and engage in the School-Based Vaccination Clinic, we do foresee that some students may be 
lost to follow-up. For example, adolescents may transfer schools due to different circumstances. 
If the child transfers from one school that is participating in the school-based clinic to another, 
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the child’s medical record will be transferred to his or her new school, and he or she will 
continue to be followed. However, if the student transfers to a school that is not participating in 
the intervention, this student will no longer be participating. In this instance, we will transfer the 
child’s comprehensive medical record to his or her pediatrician if we received consent to do so. 
This will, hopefully, encourage the pediatrician to complete the HPV vaccination series. If a 
female student becomes pregnant before the first-dose of the vaccine series she will be ineligible 
to participate in the program due to the vaccine being contraindicated in pregnant females. She 
will be encouraged to receive the vaccine if she continues school after delivering her baby. If a 
student becomes pregnant between the first- and second-dose of the vaccine, she will be 
encouraged to receive the second vaccination after delivering her baby. The medical record will 
assist the nursing staff in maintaining contact with these individuals. Finally, if a child 
experiences a serious adverse reaction to the vaccine, it will be recorded in their medical record 
and they will be contraindicated from receiving the subsequent dose of the vaccine. 
 We hope that the relationships built and fostered between the CVDHD, the education 
provided to and passion instilled in the students, and support from the community due to the 
School-Based Vaccination Clinics for the HPV9 Vaccine will allow the program to continue 
after grant funding ends. If this program increases vaccination rates within the participating 
counties, as we expect, we hope to expand the program to the remaining counties in the CVADD 
in future years. 
Adaptations 
 Our School-Based HPV9 Vaccination Clinic will consist of two minor adaptations from 
the original interventions, as executed in Guilford County, North Carolina and the Lake 
Cumberland region of Kentucky. The first is the way in which consent forms will be delivered to 
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the students. Although paper forms will still be given to each student, parents will also be sent a 
link in which they can fill out the form online and have the option to complete the forms during 
the Back-to-School Events. The additional source of the consent form was added due to low 
return rates of about 50% in a previous implementation of the program18. We hope to reach more 
parents with the consent forms than in the original model. For example, if a student is given a 
consent form at school but forgets or neglects to give it to their parent once they get home, this 
new method of consent may help to increase consent rates. Secondly, we hope to eliminate the 
barrier of turning the consent form in given a child may lose it or forget to turn it in at school. 
 The second adaptation that will be made to this program is that it will be offered to both 
female and male students in a 2-dose series. This will be done in order to reflect the current 
ACIP recommendations. By offering the vaccine to all students within the designated grades, we 
hope to decrease the incidences of both cervical cancers and head and neck cancers, as well as 
provide students with the additional benefits that the vaccine series has to offer. Moreover, we 
hope to eliminate any gender biases that may have been associated with the HPV vaccine 
previously. 
Performance Measures and Evaluation 
Process Evaluation 
 The program will utilize a process evaluation as recommended by the CDC in order to 
determine if the program is being implemented as planned, determine any barriers to 
implementation, and identify who is being reached by the program. The process evaluation will 
also consist of a financial analysis to ensure that the cost of implementing the program remains 
within the budget set forth in Appendix I. The data collected as part of the process evaluation 
will be utilized to adapt the program as warranted.  
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 The consent forms that are sent to parents both electronically and in paper format will 
contain basic demographic information that will be valuable to the study. In addition to asking 
for vaccination consent, the form will ask for information regarding the adolescent’s sex, age, 
insurance status (either insured, Medicaid/KCHIP, or no insurance), and prior doses of the HPV 
vaccine18. Collecting information on these measures will allow the Evaluation Team to 
determine groups of children that are being missed by the implementation strategy and identify 
ways to include these groups of individuals in future semesters of the program and studies. 
 In order to ensure that the School-Based HPV9 Vaccination Clinics are implemented as 
planned, both the Program Coordinator and the Assistant Coordinator will be present on all clinic 
days. They will be well-trained in the program implementation process and ways to course-
correct to guarantee fidelity of the program. In addition, the nurses will complete study logs 
during and immediately following their experiences on clinic days. These logs will be used to 
document clinic processes as they have been implemented rather than intended17. The Evaluation 
Team will review these logs after each semester and compare their outputs to the intended 
processes. The leadership team will plan additional training sessions if warranted based on the 
results from the nurses’ logs.  
 After the School-Based Vaccination Clinics, two different post-surveys will be given to 
parents and guardians of adolescents who returned consent forms. For those who gave consent 
for their children to be vaccinated, the Post-Vaccination Parent/Guardian Survey will 
characterize the reasons for which parents gave consent, prior barriers to vaccination, and 
evaluation of the School-Based Vaccination Clinic. This survey is shown in Appendix C. Parents 
will be encouraged to choose as many answers as they feel reasonable rather than limit 
themselves to one answer choice. For those parents that declined to give vaccination consent, a 
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separate Declined Consent Parent/Guardian Survey will be sent in order to determine barriers to 
obtaining this consent19. This survey will consist of one question and is presented in Appendix 
D. Again, parents will be encouraged to choose multiple answers if they feel it is necessary to 
comprehensively answer the question. If there are a large number of parents who show 
displeasure with the evaluation of the School-Based Vaccination Clinic or who decline consent 
for vaccination, focus groups will be formed in order to further discuss this displeasure or 
barriers to consent. The outcomes of these focus groups will be used to make adaptation to the 
program and determine ways to overcome barriers to consent in future semesters.  
Outcome Evaluation 
 In order to accurately assess the impact of the School-Based HPV9 Vaccination Clinic on 
immunization rates and other outcomes, our study will operate as a cluster wait-list controlled 
trial with a pilot period. Each school will serve as its own cluster. One school, CCMS, will serve 
as the pilot and will be the only school participating in the program during the first year. One 
additional school will be added to the study in each year thereafter, so that all schools will be 
participating in the intervention in the final year of the study period. 
 The primary outcomes assessed during this study will be HPV9 vaccination initiation and 
completion rates. These analyses will be conducted in two different manners. In the first analysis 
of each, only those who returned consent forms will be assessed in order to provide a 
straightforward interpretation of those choosing to participate in the program. A second analysis 
will be conducted in which school-wide vaccination rates will be considered. If an adequate 
amount of consent forms are returned to the schools with vaccination records, these materials 
will be used in order to determine the baseline vaccination initiation and completion rates. If not 
enough are returned, unfortunately, state-level data will have to be used as an estimate for these 
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three counties. Each time a vaccine is given or a series is completed throughout the study, it will 
be noted by the researchers. The post-program vaccination completion rates will be computed 
based on baseline data and those given as part of the program18. Additionally, at the end of 
program implementation, we will assess our data at the CVDHD and contact local health 
departments and pediatrician offices to determine if more parents/guardians decided to have their 
children vaccinated during the study period, but outside of our School-Based Vaccination Clinic. 
 Secondary outcomes assessed will include parents/guardians’ existing knowledge of HPV 
vaccination and biases associated with the HPV vaccination and vaccinations in general. In order 
to assess these measures an adaptation of the UNC National Parents Survey regarding questions 
and concerns about HPV vaccination will be used. This survey was originally available online 
and intended to compare communication methods about HPV9 vaccination; however, it includes 
topics such as vaccination history, general vaccine attitudes, and HPV vaccine attitudes that 
would be beneficial to assess as a part of our School-Based Vaccination Clinics23. Our iteration 
of the parent/guardian survey is available in Appendix E. 
 The original survey items have been previously validated in studies of parents, 
adolescents, and healthcare providers. Some items were adapted from other sources. The fully 
developed survey was cognitively tested with a convenience sample of 16 parents/guardians of 
adolescents who were aged 9 to 17 to confirm that participants understood items as intended. 
Additionally, the instrument was pre-tested with 31 parents from the national panel.23 
 The measure will be available to the parents/guardians before vaccination at the Back-to-
School Events, as well as, with the consent packets both in paper format and electronically. The 
clusters that are not receiving the intervention will serve as the baseline knowledge and control 
for this portion of the study as they will not be present at Back-to-School Events yet. These 
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parents/guardians will receive the survey as part of their adolescent’s packet at the beginning of 
the school year. All parents/guardians who complete the survey will receive a $5 Walmart gift 
card. The results of the surveys will be assessed for patterns and compared between the two 
groups. 
 A logic model detailing our anticipated inputs, activities, and short- and long-term 
outcomes is provided in Appendix G. Our leadership team formulated this model based on the 
Health Belief Model, the theory we hope to follow during program implementation. We believe 
we will address students’ and parents/guardians’ perceived susceptibility and severity of HPV 
and perceived benefits of receiving a preventive HPV vaccine through education delivered 
during back-to-school events. We anticipate decreasing perceived barriers to action by bringing 
the clinic directly into the middle schools and assessing and intervening on additional barriers. 
These factors will cue parents and guardians to action, and their children will participate in our 
School-Based HPV9 Vaccination Clinic. 
Capacity and Experience of the Applicant Organization 
 The mission of the Cumberland Valley District Health Department (CVDHD) is “to 
improve and protect the health of individuals, families, and the public by implementing 
preventative health services that focus on individual and population-based health promotion to 
prevent disease, injury, and disability”15. This district health department has served the following 
counties for 46 years: Bell, Clay, Harlan, Jackson, Knox, Laurel, Rockcastle, and Whitley. We 
have long-standing coalitions with the Clay, Jackson, and Rockcastle County Health 
Departments. We have existing school health initiatives in the aforementioned counties’ schools 
that include having a health department nurse present to assist in preventive services such as 
well-child screening and immunizations, in addition to referral services and assessment and 
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treatment under physician collaborations and protocols. We confidently believe that the proposed 
School-Based HPV9 Vaccination Clinic aligns with our vision to become a healthy community 
in which the members have complete access to high quality care. 
 The department and its staff have experience implementing multiple programs within the 
CVADD including the following: partnership with the Health Access Nurturing Development 
Services (HANDS) program, syringe exchange programs, diabetes prevention and awareness 
programs for children and adults, and preventive cancer screenings. More specifically, within the 
Clay County, Jackson County, and Rockcastle County schools, they have hosted educational 
events detailing physical activity, healthy eating, and hand hygiene and have, most recently, 
provided filtered water-bottle filling stations. Most closely related to the Vaccination Clinic, we 
provide Td, Tdap, influenza, MMR, and Hepatitis A vaccinations on-site.  
We also have strong partnerships with the county health departments in which we serve 
and have been actively involved in the training, implementation, and evaluation of multiple 
programs with them. Healthy Clay is comprised of goals in which they hope to meet by 2022. 
We have worked closely with them on these initiatives, one of them being to integrate healthy 
living and wellness into the school curriculum. Our collaboration has built gardens at Clay 
County schools to provide food and knowledge of healthy eating patterns. We have partnered 
with Jackson County Healthy Communities to develop and enhance access to walking and biking 
paths within the community. These paths include access to all Jackson County schools. We have 
collaborated with the Rockcastle County Health Department to establish greenhouses in all 
county schools and participate in Farm to Table programs. In addition, we partnered with them to 
enroll students in RocketReader programs to increase reading speed and scores15. These prior 
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initiatives and collaborations including the target population will encourage adolescents and 
parents to participate in the CAG and foster support that may not have existed otherwise.  
 The CVDHD is led by Public Health Director Lainey Greene. Ms. Greene has experience 
implementing programs in her current role such as the syringe exchange program and was the 
lead in implementing the diabetes prevention program for children. In past roles, she has 
implemented mentorship programs for children from grade school through high school. She 
prides herself on having strong communication, education, and leadership skills and her past 
experiences are evidence of her commitment to improving the health of children in Appalachia 
Kentucky. For the past 4 years, Ms. Greene has managed the CVDHD budget of over $1,150,000 
and serves as the supervisor of 38 committed employees. 
 In 2016, Rockcastle Regional Hospital and Respiratory Care Center performed a 
Community Health Needs Assessment (CHNA) in accordance with the National Association of 
County and City Health Officials’ recommendations of Rockcastle County and 14 surrounding 
counties. As part of this assessment, CVDHD assisted in evaluating the 2013 strategic priorities 
and developed the following 3 strategic priorities for the 2017-2019 fiscal years: cancer care and 
prevention, health education, and mental health and substance abuse24. A School-Based HPV9 
Vaccination Clinic will effectively fill a previous gap in the cancer care and prevention strategic 
priority. Our program can partially be evaluated as part of the 2021 CHNA. 
Additionally, the CVDHD does not and shall not discriminate on the basis of age, 
disability, sex, race, color, national origin, religion, sexual orientation, gender identity, or reprisal 
or retaliation for prior civil rights activity in any of its activities or operations. These activities 
include hiring and firing of staff, selection of volunteers, and delivery of services. If 
administration of CVDHD discovers that any member or collaborator on a project is in violation 
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of this policy, that member shall be permanently terminated from the organization and banned 
from the project. 
Partnerships and Collaborations 
The CVDHD has a long-lasting history of foundational partnerships, and the 
collaboration on the proposed School-Based HP9V Vaccination Clinics will be no different. As 
the program will physically take place within the middle schools in the region, one of the most 
integral partnerships has already been developed with the middle schools in the area. The 
principles of each middle school participating in this program have voiced their support of the 
program through a letter of commitment. These letters of commitment are available in Appendix 
H. In addition to providing the vaccination clinic services, representation from the CVDHD has 
agreed to meet with the principals of each school to determine any additional services that can be 
provided through them to increase the health of the students in the region. 
However, the School-Based Vaccination Clinic will rely on many other partnerships. 
Fortunately, many individuals and organizations have already voiced support and commitment to 
collaboration with the CVDHD for implementation of the proposed program. The following 
table illustrates those who have already given support and roles in implementation of the School-
Based HPV9 Vaccination Clinic. 
Table 2: Partnerships and Collaborations 
Collaborative Organization Representative/Liaison 
Role 
MCC Affiliate Networks Dr. Jacob Wilkins; 
Oncologist at Rockcastle 
Regional Hospital and 
Respiratory Care Center 
MCC will assist with 
determining baseline data for 
HPV-associated cancer rates. 
In addition, they are 
responsible for ensuring that 
all education regarding HPV-
associated cancers provided 
to students and 
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parents/guardians is 
medically accurate and 
current. They will have 
access to all outcome data at 
the conclusion of the 
intervention period and have 
the ability to track long-term 
outcomes. 
Kentucky Health 
Departments Association 
(KHDA) 
Eryne Wiethorn, MPH; 
Member, PC, and CAG 
member 
KHDA will provide resources 
and ideas as needed to 
implement the program to the 
highest fidelity and 
accessibility to our 
population. They will assist in 
gathering and confirming 
state-level data for measures 
and will have access to all 
outcomes data at the 
conclusion of the program. 
American Academy of 
Pediatrics (AAP) 
Dr. Margaret Roberts; 
Pediatrician at Baptist Health 
Corbin Primary Care and 
CAG member 
The Kentucky Chapter 
currently has an initiative 
titled “HPV Focus”. AAP 
will be responsible for 
assuring that all materials 
covered in vaccine 
administration training is 
appropriate practice for our 
adolescent population and 
that adequate education is 
provided to all staff involved 
in clinics. At the end of our 
program, we will provide 
them with the entirety of our 
outcome data.  
American Nurses Association 
(ANA) 
Michaela Sherman; RN, 
BSN, AC, and CAG member 
Responsible for 
communicating any updates 
to nursing policy or best 
practices in regard to vaccine 
administration and HPV 
vaccination to clinic nursing 
staff and leadership. In return, 
all nurses involved with the 
program will be paid ANA 
members. 
Kentucky Cancer Consortium 
(KCC) 
Brooke Dean; Cumberland 
Valley District Cancer 
Brooke has personally agreed 
to tell her story at Back-to-
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Program Representative and 
survivor of cervical cancer 
School recruitment events 
and the KCC will assist with 
recruitment efforts. The 
CVDHD will continue to 
advertise all KCC events in 
the region, whether they 
relate closely to the proposed 
program or not. 
Student Government 
Association 
Gabriella Hamilton; SGA 
President at Jackson County 
Middle School, CAG 
member, and student 
SGA at each school will be 
responsible for designing 
posters and determining 
appropriate engagement 
activities and times to foster 
student participation in the 
School-Based Vaccination 
Clinics. 
UK College of Public Health Nicholas West, PhD; 
Associate Professor in the 
Department of Health, 
Behavior & Society 
UK College of Public Health 
will assist in recruitment 
efforts of two graduate-level 
students who are interested in 
and capable of becoming 
research assistants for this 
project.  
Kentucky Rural Health 
Association (KRHA) 
Dr. Christopher Jones; 
Member and Primary Care 
Physician at White House 
Clinic in McKee, KY 
KRHA will ensure that all 
materials are culturally 
appropriate for our rural 
population of both 
adolescents and 
parents/guardians. They will 
partner with us to provide 
contact information to 
adolescents without a Primary 
Care Provider or pediatrician.  
Clay, Jackson, and 
Rockcastle County School 
Boards 
Megan Wiggins; Clay County 
School Board Vice President, 
mother, and CAG member 
The school boards will assist 
with assessing and 
overcoming barriers to 
program implementation and 
negative connotations 
associated with the HPV 
vaccine.  
 
Project Management 
Leadership 
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 To meet the goals set forth above, the School-Based HPV9 Vaccination Clinic will be 
directed by a set of three leaders. The leaders of the program will consist of the Program 
Director, Program Coordinator, and Assistant Coordinator. They will have a presence at all of 
the school-based clinics and ensure that the program is implemented and evaluated as planned. 
They will also make any decisions in regard to program implementation and evaluation in order 
to accurately represent our CAG. 
Program Director 
Lainey Greene, MPH, will serve as the Program Director (PD) of the School-Based 
HPV9 Vaccination Clinic. Ms. Lainey Greene earned her Master of Public Health (MPH) Degree 
from Eastern Kentucky University in 2011. She currently serves as the Public Health Director for 
the CVDHD and has over 10 years of experience working at the Madison County Health 
Department in various capacities. Her primary responsibilities will include program design, 
implementation, and evaluation. Additionally, she will be accountable for financial supervision 
of the program. 
Program Coordinator 
Eryne Wiethorn, MPH, will serve as the Program Coordinator (PC) for our clinics. She 
received her MPH from UK and serves as the current Program Analyst of the CVDHD. She has 
previous experience in implementing and analyzing the district health department’s current 
initiatives in school health and clinical services, including immunizations. Ms. Wiethorn will 
assist the PD in the design, implementation, and evaluation of the program. Her primary 
responsibilities will include (1) day-to-day oversight of the program, (2) training of the assistant 
coordinator and additional staff, (3) data collection, (4) maintaining a relationship with the key 
stakeholders in the region, and (5) organizing quarterly update meetings with the CAG. 
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Assistant Coordinator 
Michaela Sherman, RN, BSN, will operate as the Assistant Coordinator (AC) for our 
program. She earned her Bachelor of Science in Nursing at UK and has three years of experience 
working as a nurse at MCC. Currently, she serves as a nurse at the CVDHD. In this role, she 
oversees the school health program in which local health department nurses are available for 
students to assist with acute illnesses and long-term management of special healthcare needs. 
Ms. Sherman will assist the PC in the day-to-day oversight of the program. Primary 
responsibilities will include (1) training of all nurses involved with vaccine administration, (2) 
administration of vaccines during clinic hours, and (3) coordination of recruitment and retention 
activities. 
Staff 
Graduate Research Assistants (GRA) 
 The School-Based HPV9 Vaccination Clinic will not be possible without additional 
support staff members. Two MPH GRAs will be hired to help implement the program. They will 
be present during the clinics and provide students with the VIS, raffle tickets, and reminder slips, 
as well as, document vaccine administration information. They will assist with data collection of 
the consent forms and vaccine administration. These MPH students will be recruited through 
recommendations with our partners at the UK College of Public Health. Before implementation 
of the School-Based HPV9 Vaccination Clinics, they will receive data collection training and 
complete required human subjects protection training. After each clinic, or once per semester, 
these students will meet individually with the PC and one of their professors to assess any 
learning needs and areas for professional development. 
Nurses 
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Additionally, the local health department nurses, whom already have a relationship with 
the schools, will be recruited to facilitate the HPV vaccination clinics before program 
implementation. Their purpose will be to review the vaccine questionnaires for appropriateness 
of administration and administer vaccinations to the students. They will also assist the AC with 
retention activities. As these nurses will have the primary responsibility for administering 
vaccinations, they will receive extensive training before program implementation. This training 
will be facilitated by the AC. Various healthcare professionals will conduct the training to 
educate them on HPV, HPV vaccination, and program implementation. They will also receive 
sensitivity training for the specific patient population. At the end of their training, they will be 
required to pass a short test in order to ensure safe administration procedures. 
Biostatistician 
A biostatistician will be hired to serve as the primary data analyst during the month of 
July before data collection. He or she will be responsible for analyzing data collected from the 
vaccine consent forms and communicating the interpretations of the data with the PD and PC. 
Once the program begins, the PD will conduct biweekly phone conferences with the statistician 
to assure that he or she is on task and to obtain any updates. 
 All leadership and staff members will complete appropriate training in order to comply 
with HIPAA regulations and to facilitate appropriate interactions with students. The PD will 
ensure that all leadership and staff members of the program are adequately compensated for their 
time and efforts to ensure minimal staff turnover 
throughout the duration of our project. The figure 
below shows the project management structure for 
the School-Based HPV9 Vaccination Clinics. Figure 5: Project Management Structure 
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Appendices 
Appendix A: HPV9 Vaccine Parental Consent Form 
Human Papillomavirus (HPV) Vaccine Consent Form 
Student’s Name_____________________________________ Age_____ Gender_______ 
Child Identifies as: ____ White  ____ African American/Black  ____ American Indian  
 ____ Asian  ____ Latino/Hispanic  ____ Other: ____________ 
Please complete the appropriate section. 
ACCEPT VACCINATION 
____ My child has not received the HPV vaccine. Yes, I consent to my child being fully 
protected by receiving the entire two (2) dose series. I understand this will be administered at 
no cost to me or my child. 
____ My child has already received the HPV vaccine but has not completed the recommended 
two (2) doses. I understand 2 doses are required for full protection. Yes, I consent for the 
remaining dose. I understand this will be administered at no cost to me or my child. The dates 
of the previous dose is: __________  
 
Does your child have an allergy to medications, foods, or latex? ____ Yes ____ No 
 If yes, please specify: _________________________________________________ 
Does your child have an allergy or hypersensitivity to yeast? ____ Yes ____ No 
Has your child had a serious reaction to a vaccination in the past? ____ Yes ____ No 
(For Females) Is your child pregnant or is there a chance she could 
become pregnant within the next month? 
____ Yes ____ No 
   
My child: ____ does not have insurance  ____ has private insurance that covers vaccinations 
                ____ is enrolled in Kentucky Medicaid ____is underinsured 
 
By signing this, I am consenting to my child receiving the recommended three doses or the remaining 
doses required for full protection. I have read or had read to me information about the HPV vaccine. I 
have been given the Vaccine Information Statement for the vaccine. I had a chance to ask questions 
which were answered to my satisfaction. I believe I understand the benefits and the risk of the vaccine 
to be administered and ask that the vaccine be given to my child. I also consent to care which may 
include, assessments, treatment, first-aid, over the counter medicine, and any other health service 
given to me/my child by staff or agents of the Cumberland Valley District Health Department. I 
understand no guarantees are being made as to the effect of any exam or treatment on me/my child. I 
like-wise release the staff from any liability related to the administering of the above vaccine to my 
child so long as the responsibility is discharged according to the manufacturer's instructions. I 
authorize the school health clinic to release medical information about my child, as permitted by the 
Health Insurance and Portability and Accountability Act of 1996 (HIPAA), to his/her primary care 
provider and to share pertinent medical information (history of allergies or significant medical history) 
with school staff who may need to provide care to my child in an emergency or in order to meet school 
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reporting requirements. I understand that the sharing of this information is on a need to know basis 
only. If my child has Medicaid or KCHIP or private insurance, I also authorize the school clinic to 
release this information to these parties so that they can be billed for visits to the school clinic. This 
permission can be revoked at any time, and will expire one year from the date signed. 
 
Signed (Parent/Guardian)_______________ Printed _______________ Date__________ 
 
DECLINE VACCINATION 
 
____ My child has already completed the recommended two (2) dose series and is fully 
protected. No, I do not consent my child to participate in the vaccination clinic. 
 
Signed (Parent/Guardian)_______________ Printed _______________ Date__________ 
 
____ No, I do not consent my child to receive the HPV vaccination series as part of the 
vaccination clinic.  
 
By signing this, I admit that I have read the Vaccine Information Sheet from the Centers for Disease 
Control and Prevention explaining the vaccine and the disease it prevents. I have had the opportunity 
to discuss this with my child’s school nurse and Program Coordinator, who have answered all of my 
questions regarding the recommended vaccine. I understand the purpose and the need for and the risks 
and benefits of the recommended vaccine. I know that failure to follow the recommendations about 
vaccination may endanger the health or life of my child and others with which my child might come in 
contact. I know that I can change my mind and accept the vaccination for my child in the future. 
 
Signed (Parent/Guardian) _______________ Printed _______________ Date __________ 
 
If you require additional information before giving consent, please contact Eryne Wiethorn, 
the Program Coordinator at eryne.wiethorn@cvhdh.gov or (606)779-3373. 
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Appendix B: Program Calendars 
  
 
Wiethorn 42 
 
  
Wiethorn 43 
  
  
 
 
 
 
 
Appendix C: Post-Vaccination Parent Survey 
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School-Based HPV9 Vaccination Clinic Post-Vaccination Parent/Guardian Survey 
Why did you decide to allow your child to be vaccinated for HPV? (check all that apply) 
____ It is the best way to prevent HPV infection 
____ The potential health consequences of HPV infection could be serious. 
____ My child’s healthcare provider recommended it. 
____ My child is, or will be, at risk of acquiring HPV. 
Why did you decide to not get your child HPV vaccinated previously? (check all that apply) 
____ HPV vaccine is too expensive. 
____ I didn’t know enough about HPV. 
____ It was inconvenient to make two appointments to receive all the shots. 
____ I didn't know enough about HPV vaccine. 
____ HPV vaccine is not mandatory for school entry. 
Feedback about the School-Based HPV9 Vaccination Clinic. (check all the apply) 
____ I was pleased with the overall experience. 
____ I would like to see more partnerships between the school system and district health 
department in the future. 
____ I would recommend School-Based Vaccination Clinics to family and friends. 
____ I felt that the information and consent packet was sufficient to make an informed 
decision.  
____ The other information I received from this project helped me to make an informed 
decision. 
 
 
 
 
Appendix D: Declined Consent Parent Survey 
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School-Based HPV Vaccination Clinic Declined Consent Parent/Guardian Survey 
Why did you choose not to have your child participate in the School-Based HPV Vaccination 
Clinic? (check all that apply) 
____ My child already received all three doses of the HPV vaccine. 
____ I am not sure the HPV vaccine is safe and effective. 
____ I am worried about potential side effects of the HPV vaccine. 
____ I do not believe my child needs the HPV vaccine. 
____ I need more information before making a decision about the HPV vaccine. 
____ Other: _______________________________________________________________ 
 
Appendix E: UNC National Parent Survey – Adapted 
Parent/Guardian HPV Vaccination Survey 
Please mark one option for each answer. 
1. How many children do you have between the ages of 9-17 in your household? ____ 
2. How many shots of the HPV vaccine has your 
youngest child between the ages of 9-17 had? 
____ None ____ 1 ____ 2 ____ 3 
3. What age did your youngest child between the 
ages of 9-17 receive the HPV vaccine? 
____ 9 _____ 10 ____ 11 ____ 12 
 ____ 13 ____ 14 _____ 15 ____ 16 ____ 17 
4. Vaccines are necessary to protect the health of middle school children. 
____ Strongly agree ____ Somewhat disagree 
____ Somewhat agree ____ Strongly disagree 
____ Neither agree nor disagree 
5. Vaccines do a good job in preventing the diseases they are intended to prevent. 
____ Strongly agree ____ Somewhat disagree 
____ Somewhat agree ____ Strongly disagree 
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____ Neither agree nor disagree   
6. If I do not vaccinate my child, he or she may get a disease such as meningitis and cause 
others to get the disease. 
____ Strongly agree ____ Somewhat disagree 
____ Somewhat agree ____ Strongly disagree 
____ Neither agree nor disagree   
7. The HPV Vaccine may cause lasting health problems. 
____ Strongly agree ____ Somewhat disagree 
____ Somewhat agree ____ Strongly disagree 
____ Neither agree nor disagree   
8. I do not have enough information about the HPV vaccine to decide whether to give it to my 
child. 
____ Strongly agree ____ Somewhat disagree 
____ Somewhat agree ____ Strongly disagree 
____ Neither agree nor disagree   
9. The HPV vaccine is effective in preventing several cancers. 
____ Strongly agree ____ Somewhat disagree 
____ Somewhat agree ____ Strongly disagree 
____ Neither agree nor disagree   
10. It would be hard to find a provider or clinic where I can afford the HPV vaccine for my 
child. 
____ Strongly agree ____ Somewhat disagree 
____ Somewhat agree ____ Strongly disagree 
____ Neither agree nor disagree   
11. Other parents in my community are getting their children the HPV vaccine. 
____ Strongly agree ____ Somewhat disagree 
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____ Somewhat agree ____ Strongly disagree 
____ Neither agree nor disagree   
12. Most people who are important to me would support getting the HPV vaccine for my child. 
____ Strongly agree ____ Somewhat disagree 
____ Somewhat agree ____ Strongly disagree 
____ Neither agree nor disagree   
13. How many vaccines do you think would be safe for a one-year old to get at a single check-
up? 
____ None ____ 3 vaccines 
____ 1 vaccine ____ 4 vaccines 
____ 2 vaccine ____ 5 or more vaccines 
14. How many vaccines do you think would be safe for an eleven-year old to get at a single 
check-up? 
____ None ____ 3 vaccines 
____ 1 vaccine ____ 4 vaccines 
____ 2 vaccine ____ 5 or more vaccines 
15. Imagine you agree to get your child the three vaccines they are due for: meningitis, HPV 
vaccine, Tdap vaccine. Would you prefer… 
____ Get all 3 vaccine at one visit ____ Spread the vaccines across multiple visits 
____ Get whatever the doctor or healthcare provider recommends 
16. Imagine your child gets the first dose of HPV vaccine today. When would you prefer he or 
she get the next dose? 
____ As soon as is recommended ____ At their next check-up 
 
 
 
Appendix F: Gantt Chart 
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Appendix G: Logic Model 
 
 
 
 
Appendix H: Letters of Commitment for the Proposed Program 
Evaluation of Outcomes and Processes
Inputs
Partners
- Schools: principals, school 
nurses, parents, students, 
school boards
- Health departments: local 
departments, development 
district department
- Implementation team, 
leadership, and staff
- Community Action Group
- MCC, AAP, ANA, KCC, 
KRHA
- SGA and other student 
organizations
Budget
- Funds for materials, 
vaccinations, and incentives
Resources
- KCR
- MMWR
- CDC
- Immunization records
Short-Term Outputs
Increase student and 
parent knowledge about 
HPV and the vaccine
Reduce barriers to the 
HPV vaccine
Long-Term Outcomes
Increase the initiation 
and completion rates of 
HPV-9 vaccination
Reduce the incidence 
and mortality of genital 
warts and HPV-related 
cancers
Activities
Preparation
- Train school nurses 
and intervention staff
- Hold Back-to-School 
Event
- Provide student 
education
Intervention
- Consent packets and 
student surveys
- Conduct vaccination 
clinics
- Collect data and send 
reminders
- Send post-
vaccination surveys
Contextual Conditions (e.g. national recommendations, media reports)
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A. Letter of Commitment from Mr. Steven Diamond, Clay County Middle School Principal 
B. Letter of Commitment from Dr. Adam Kirby, Jackson County Middle School Principal 
C. Letter of Commitment from Mr. Michael Robin, Rockcastle County Middle School 
Principal 
Appendix I: Budget and Justification 
The Grant budget is proposed for July 1, 2019-June 30, 2022. 
Anticipated Enrollment 
As outlined in the “Target Population and Need” section on page 3, our program has the 
potential to reach approximately 1,340 students over the three-year course of this grant. 
However, we assume that 40% of our students will be UTD on their HPV vaccination before 
implementation and that many students will not return consent forms. Therefore, we anticipate 
that 50% of eligible students will enroll in the program, or about 670 students. On average, we 
estimate that about 225 students will enroll in our School-Based HPV9 Vaccination Clinic each 
year. More specifically, we estimate that 125 students will be enrolled in Year 1, 235 students 
will be enrolled in Year 2, and 310 will be enrolled in Year 3. This will allow us to utilize 
$250,000 per year, or $750,000 total over the duration of the grant. 
Personnel 
Table 3: Personnel Budget Year 1 
Year 1 Effort Salary  Fringe Total 
Program Director 20.00% $100,000 $20,000 $5,486 $25,486 
Program Coordinator 70.00% $80,000 $56,000 $16,226 $72,226 
Assistant Coordinator 50.00% $60,000 $30,000 $9,465 $39,465 
MPH GRA 1 33.00% $32,000 $10,560 $4,283 $14,843 
Wiethorn 50 
MPH GRA 2 33.00% $32,000 $10,560 $4,283 $14,843 
CCMS Nurse 6.00% $40,000 $2,400 $881 $3,281 
RCMS Nurse 0% $40,000 $0 $0 $0 
JCMS Nurse 0% $40,000 $0 $0 $0 
Biostatistician 5.00% $35,000 $1,750 $681 $2,431 
Total   $131,370 $41,305 $172,675 
 
Table 4: Personnel Budget Year 2 
Year 2 Effort Salary  Fringe Total 
Program Director 10.00% $103,000 $10,300 $2,825 $13,125 
Program Coordinator 80.00% $82,400 $65,920 $19,100 $85,020 
Assistant Coordinator 50.00% $61,800 $30,900 $9,749 $40,649 
MPH GRA 1 33.00% $32,960 $10,877 $4,412 $15,289 
MPH GRA 2 33.00% $32,960 $10,877 $4,412 $15,289 
CCMS Nurse 6.00% $41,200 $2,472 $907 $3,379 
RCMS Nurse 6.00% $41,200 $2,472 $907 $3,379 
JCMS Nurse 0% $40,000 $0 $0 $0 
Biostatistician 5.00% $36,050 $1,803 $701 $3,379 
Total   $135,621 $43,013 $178,634 
 
Table 5: Personnel Budget Year 3 
Year 3 Effort Salary  Fringe Total 
Program Director 10.00% $106,090 $10,609 $2,910 $13,519 
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Program Coordinator 80.00% $84,872 $67,898 $19,673 $87,571 
Assistant Coordinator 50.00% $63,654 $31,827 $10,041 $41,868 
MPH GRA 1 40.00% $33,949 $13,580 $5,508 $19,088 
MPH GRA 2 40.00% $33,949 $13,580 $5,508 $19,088 
CCMS Nurse 6.00% $42,436 $2,546 $934 $3,481 
RCMS Nurse 6.00% $42,436 $2,546 $934 $3,481 
JCMS Nurse 6.00% $42,436 $2,546 $934 $3,481 
Biostatistician 10.00% $37,132 $3,713 $1,445 $5,158 
Total   $148,845 $47,887 $196,732 
 
 The majority of the budget for the School-Based HPV9 Vaccination Clinic will be 
dedicated to the salaries and other benefits of the personnel implementing the program. While 
the PD will be charged with overseeing the design, implementation, and evaluation of the 
program, as well as have all financial responsibilities, she will have few hands-on responsibilities 
of implementation. We expect her to spend only 20% of her time on our project in Year 1 and 
10% of her time in the two subsequent years. The PC will have the direct oversight, data 
collection, and training responsibilities. Therefore, we expect her to spend the majority of her 
time on our project. The AC will be expected to be present on all clinic days and will assist in the 
retention process by contacting students and their parents to remind them to complete the second 
dose of the vaccine series. She will also be responsible for training all other nurses involved in 
the program. Therefore, we expect the AC to spend 100% of her time on this program for 6 
months out of each year. 
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 The MPH GRAs will be hired for 20 hours per week. These assistants will be present at 
the clinics in order to distribute VIS, incentive tickets, and reminder slips and document vaccine 
administration. They will also aid in data collection and interpretation year-round. The local 
health department nurses that are already affiliated with each of the schools included participate 
in the program by administering vaccines to appropriate students. The clinics will be at each 
school for 20 days out of the year. By including time for training, we will reimburse them for 
almost one-month’s salary. We expect the additional nurse to be present during all clinic days at 
each school to assist in the previously mentioned activities. Additionally, he/she will assist the 
AC with reminders for second doses. We will also hire a biostatistician to assist in analyzing our 
data. We will expect this person to spend approximately 5% of their time on our project during 
Years 1 and 2. However, we would like the statistician to spend more time during Year 3 in order 
for us to draw final conclusions for our project. 
Equipment 
 The only equipment that we plan on purchasing for our intervention is two School-Based 
HPV9 Vaccination Clinic laptops that are to be used solely for the purpose of our project. We 
will purchase two MacBook Airs, priced at $1,100 each for a total of $2,200. 
Supplies 
Table 6: Supply Budget 
 Number  Unit Cost Year 1 Year 2  Year 3  
PROGRAM SUPPLIES 
HPV$$609 
Vaccine 
100 (Y1); 
190 (Y2); 
250 (Y3) 
$168.10 $16,810 $31,939 $42,025 
Needles 250 (Y1); 
470 (Y2);  
620 (Y3) 
$0.20 $50 $94 $124 
Gloves 500 (Y1); 
940 (Y2) 
1,240 (Y3) 
$0.12 $60 $112.80 $148.80 
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Bandages 250 (Y1); 
470 (Y2); 
620 (Y3) 
$0.10 $25 $47 $62 
Alcohol Swabs 250 (Y1); 
470 (Y2); 
620 (Y3) 
$0.16 $40 $75.20 $99.20 
Cotton Balls 250 (Y1); 
470 (Y2); 
620 (Y3) 
$0.01 $2.50 $4.70 $6.20 
Hand Sanitizer 12 (Y1); 24 
(Y2); 36 
(Y3) 
$3 $36 $72 $108 
Paper 1,860 sheets 
per year 
1,500 for $28 $56 $56 $28 
Ink 6 cartons per 
year 
$20 $120 $120 $120 
Raffle Ticket 250 (Y1); 
470 (Y2); 
620 (Y3) 
2,000 for $10 $10 $0 $0 
Reminder Cards 125 (Y1); 
235 (Y2); 
310 (Y3) 
$0.05 $6.25 $11.75 $15.50 
INCENTIVES 
Gift Cards for 
Parents 
620 per year $5 $3,100 $3,100 $3,100 
Basket Materials 3 (Y1); 6 
(Y2); 9 (Y3) 
$50 $150 $300 $450 
Pizza Party 
Materials 
1 (Y1); 2 
(Y2); 3 (Y3) 
$200 $200 $400 $600 
RECRUITMENT SUPPLIES $1,000 $500 $500 
Totals $21,666 $36,832 $47,387 
Total $105,885 
  
A substantial portion of the funds needed for this program will be used in order to acquire 
the HPV9 vaccines themselves. While we are estimating that 125 students will utilize our clinics 
in Year 1, 235 in Year 2, and 310 in Year 3, we estimate that at least 39% of these students will 
be enrolled in Kentucky Children’s Health Insurance Program (KCHIP), as this is the current 
national coverage rate25.We will bill KCHIP for our services and estimate the ability to bill for 
approximately 20% of additional vaccines through private insurance companies. Therefore, we 
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only estimate to accrue the cost of about 100 vaccines in Year 1, 190 vaccines in Year 2, and 250 
vaccines in Year 3. We will also need to purchase all other medical supplies (gloves, bandages, 
needles, etc.) needed to administer the vaccines. While we will not have to purchase a printer, we 
will supply our own paper and ink in order to print the VIS, reminder cards, consent forms, and 
surveys. Additionally, we will budget a set amount of money for raffle tickets, prize baskets, and 
pizza parties each year for incentive purposes. We will budget $3,100 per year to put towards $5 
Walmart gift cards for parents or guardians who return both the pre-clinic survey and post-clinic 
survey in addition to the consent form. We will also reserve money to be used for recruitment 
activities. We expect to spend about double the funds on recruitment during the first year 
compared to the two subsequent years. 
Travel 
Table 7: Travel Budget 
 Year 1 Year 2 Year 3 
Local Travel $300 $300 $300 
APHA Meeting Registration $1,000 $1,000 $1,000 
Airfare $1,000 $1,000 $1,000 
Overnight $1,000 $1,000 $1,000 
Total $3,300 $3,300 $3,300 
 
 The leadership and staff members of our program will be required to travel locally to the 
schools in order to implement the program and attend trainings. The schools furthest from each 
other are Rockcastle County Middle School and Clay County Middle School with a distance of 
44 miles. The MPH GRAs will also be required to travel from UK to the CVADD, totaling about 
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96 miles, in order to participate about 5 times per year. We will reimburse mileage based on the 
standard mileage rates of 54.5 cents per mile. We will reserve $3,000 per year in our budget for 
these purposes. 
 Additionally, we plan to have two leadership members attend the American Public Health 
Association annual conference. We will budget for the members’ registration, travel, and lodging 
fees. We are estimating that the registration fees will be about $500 each, airfare will be $500 
each, and each room will cost about $250 per night for two nights. 
Training 
Table 8: Training Budget 
 Year 1 Year 2 Year 3 
Fee for service $1,500 $1,500 $1,500 
Room $400 $400 $400 
Nurse-specific training $750 $750 $750 
Food $300 $300 $300 
Total $2,950 $2,950 $2,950 
 
 In order to ensure that those implementing the program are educated on the program in its 
entirety, we will hold a 4-hour training event before the recruitment process for the program 
begins. We anticipate spending $50/hour in order to rent a room to host this event. We will also 
provide a meal for all who attend as well as reimburse them for their time. We will hold a similar 
2-hour abbreviated training event before the school year starts in order to ensure fidelity of the 
program over time. Additionally, we will hold a nurse-specific hour-long training session at the 
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beginning of each school year. This training will cover what the nurses should be reviewing from 
the vaccination questionnaires and proper administration techniques. 
Other Expenses 
 In addition, tuition is requested for the two GRAs in agreement with UK’s policy. Tuition 
estimates have been calculated based on current in-state rates and are projected to increase by 
approximately 10% each year. Quarterly, we will meet with the CAG in order to discuss our 
progress and share ideas, thoughts, and concerns regarding HPV, HPV9 vaccination, and our 
School-Based Clinic. We will budget $15/person for meals at each of these meetings. 
Final Budget Sheet 
Table 9: Cumulative Budget Sheet 
Category Year 1 Year 2 Year 3 
Personnel $131,370 $135,621 $148,845 
Fringe $41,305 $43,013 $47,887 
Tuition $22,000 $24,200 $26,620 
Equipment $2,200 $0 $0 
Supplies $21,666 $36,832 $47,387 
Travel $3,300 $3,300 $3,300 
Training $2,950 $2,950 $2,950 
CAG Meetings $720 $720 $720 
Totals $225,511 $246,636 $277,709 
Total   $749,856 
 
